Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Mosapride in GERD
NCT00729339Phase 4Completed
- Sponsor
- Lotung Poh-Ai Hospital
- Start
- Jun 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mosapride in gastroesophageal reflux disease (GERD), sponsored by Lotung Poh-Ai Hospital. Started Jun 2008; status: completed.
02
Drugs
mosapride
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00729339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729339.